Preparation and characterization of piperine multilamellar vesicular liposomes intended for testing anticonvulsant activity in rats

Indian Drugs

Volumn 44, Issue 6, 2007, Pages 458-465

  Bonepally, C R ^a   Challa, S R ^a   Yellu, N R ^a   Akkaladevi, M ^a   Aukunuru, J V ^a  

^a Vaagdevi College of Pharmacy   (South Korea)

Author keywords

Formulation; Hydration; Liposomes; Piperine; Time

Indexed keywords

EID: 79251475480     PISSN: 0019462X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Indian Herbal Pharmacopoeia, 2002. Published by Indian Drug Manufacturers Association. PP. 317-326
2. Mori A, Kabuto H, Pei YQ Effects of piperine on convulsions and on brain serotonin and catecholamine levels in E1 mice. Neurochem Res. 1985 Sep;10(9):1269-75 (Pubitemid 15242645)
3. D'Hooge R, Pei YQ, Raes A, Lebrun P, van Bogaert PP, de Deyn PP. Anticonvulsant activity of piperine on seizures induced by excitatory amino acid receptor agonists. Arzneimittelforschung. 1996; 46(6):557-60
4. Brocks DR, Betageri GV. Enhanced oral absorption of halofantrine enantiomers after encapsulation in a proliposomal formulation. J Pharm Pharmacol. 2002 Aug;54(8):1049-53
5. Piotr Slifriski, Liposomes as drug delivery systems. Summer 2002. Pharmaceutical Manufacturing and Packing Sourcer.
6. Amrite AC, Ayalasomayajula SP, Cheruvu NP, Kompella UB. Single periocular injection of celecoxib-PLGA microparticles inhibits diabetes-induced elevations in retinal PGE2, VEGF, and vascular leakage. Ophthalmol Vis Sci. 2006;47(3):1149-60
7. G. Gregordiadis, P.D. Leathwood, and BE Ryman, Enzyme entrapment in liposomes, FEBS Lett., 14:95-99. 1971.
8. Khuller GK, Kapur M, Sharma S Liposome technology for drug delivery against mycobacterial infections. Curr Pharm Des. 2004;10(26):3263-74. (Pubitemid 39276614)
9. Bangham AD, Standish MM, Watkins JC. Diffusion of univalent ions across the lamellae of swollen phospholipids. J Mol Biol. 1965 Aug;13(1):238-52.
10. Sunkara G, Mada SR, Vobalaboina V. Pharmacokinetics and tissue distribution of piperine in animals after i.v. bolus administration. Pharmazie. 2001; 56(8):640-2 (Pubitemid 32751854)
11. 10 following oral supplementation. J Nutr Biochem. 2000; 11:109-113.
12. Shoba G, Joy D, Joseph TM, et al. Influence of piperine on the pharmacokinetics of curcumin in animals and human volunteers. Planta Med. 1998; 64:353-356. (Pubitemid 28234275)
13. Badmaev V, Majeed M, Norkus EP. Piperine, an alkaloid derived from black pepper increases serum response of beta-carotene during 14-days of oral beta-carotene supplementation. Nutr Res. 1999; 19:381-388. (Pubitemid 29164841)
14. Bano G, Raina RK, Zutshi U, et al. Effect of piperine on bioavailability and pharmacokinetics of propanolol and theophylline in healthy volunteers. Eur J Clin Pharmacol. 1991; 41:615-617.
15. Atal CK, Dubey RK, Singh J. Biochemical basis of enhanced drug bioavailability by piperine: evidence that piperine is a potent inhibitor of drug metabolism. J Pharmacol Exp Ther. 1985; 232:258-262. (Pubitemid 15193683)
16. Karekar VR, Mujumdar AM, Joshi SS, et al. Assessment of genotoxic effect of piperine using Salmonella typhimurium and somatic and somatic and germ cells of Swiss albino mice. Arzneimittelforschung. 1996; 46:972-975.
17. Justo OR, Moraes AM. Kanamycin incorporation in lipid vesicles prepared by ethanol injection designed for tuberculosis treatment. J Pharm Pharmacol. 2005 Jan;57(1):23-30.
18. Reddy PR, Venkateswarlu V. Pharmacokinetics and tissue distribution of etoposide delivered in long circulating parenteral emulsion. J Drug Target. 2005 Dec;13(10):543-53 (Pubitemid 43101953)